LF
Lifecore Biomedical, Inc.
LFCR · NASDAQ
$4.40 +2.33% (+$0.10)
1M -2.03%
Market Cap $163.2M
P/E Ratio -
Div. Yield -
ROE 376.95%
Piotroski F-Score Moderate
4/9Valuation
96 /100
Cheap P/S 1.33x
P/FCF N/A
P/B N/A
Growth
35 /100
Stable Book val. growth 75.22%
Rev. growth 5.02%
FCF growth N/A
Profitability
11 /100
Weak FCF margin 1.47%
Op. margin 2.12%
Gross margin 29.68%
Quality
7 /100
Poor Asset turnover 0.53x
ROA 16.25%
ROIC 1.26%
Debt
43 /100
Moderate Int. coverage -0.46x
Current ratio 3.87x
Net debt/EBITDA N/A
Stability
40 /100
Moderate Profitable years 0
EPS volatility 319.83%
Beta 1.09x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LFCR
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Paul Josephs
Employees
382
Headquarters
Chaska
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report